These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19047049)

  • 21. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFkappaB and p38 MAP kinase in articular chondrocytes.
    Ohno S; Im HJ; Knudson CB; Knudson W
    J Biol Chem; 2006 Jun; 281(26):17952-60. PubMed ID: 16648633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
    Hiscox S; Baruha B; Smith C; Bellerby R; Goddard L; Jordan N; Poghosyan Z; Nicholson RI; Barrett-Lee P; Gee J
    BMC Cancer; 2012 Oct; 12():458. PubMed ID: 23039365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frizzled 7 expression is positively regulated by SIRT1 and β-catenin in breast cancer cells.
    Simmons GE; Pandey S; Nedeljkovic-Kurepa A; Saxena M; Wang A; Pruitt K
    PLoS One; 2014; 9(6):e98861. PubMed ID: 24897117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
    Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
    Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NFκB- and AP-1-mediated DNA looping regulates matrix metalloproteinase-9 transcription in TNF-α-treated human leukemia U937 cells.
    Chen YJ; Chang LS
    Biochim Biophys Acta; 2015 Oct; 1849(10):1248-59. PubMed ID: 26260845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol inhibits matrix metalloproteinase-1 and -3 expression by suppressing of p300/NFκB acetylation in TNF-α-treated human dermal fibroblasts.
    Lu YE; Chen YJ
    Chem Biol Interact; 2021 Mar; 337():109395. PubMed ID: 33515544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt/β-catenin-dependent acetylation of Pygo2 by CBP/p300 histone acetyltransferase family members.
    Andrews PG; Kao KR
    Biochem J; 2016 Nov; 473(22):4193-4203. PubMed ID: 27647933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells.
    Fang XJ; Jiang H; Zhu YQ; Zhang LY; Fan QH; Tian Y
    Oncol Rep; 2014 Jun; 31(6):2735-42. PubMed ID: 24715151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.
    Bouras T; Fu M; Sauve AA; Wang F; Quong AA; Perkins ND; Hay RT; Gu W; Pestell RG
    J Biol Chem; 2005 Mar; 280(11):10264-76. PubMed ID: 15632193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
    Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
    Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth.
    Ghosh-Choudhury N; Mandal CC; Ghosh-Choudhury N; Ghosh Choudhury G
    Cell Signal; 2010 May; 22(5):749-58. PubMed ID: 20060890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
    Bourguignon LY; Gilad E; Peyrollier K
    J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription.
    Amat R; Solanes G; Giralt M; Villarroya F
    J Biol Chem; 2007 Nov; 282(47):34066-76. PubMed ID: 17884810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC.
    de Jong E; Winkel P; Poelstra K; Prakash J
    PLoS One; 2011; 6(9):e25192. PubMed ID: 21957481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous modulation of COX-2, p300, Akt, and Apaf-1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells.
    Wang J; Xiao X; Zhang Y; Shi D; Chen W; Fu L; Liu L; Xie F; Kang T; Huang W; Deng W
    J Pineal Res; 2012 Aug; 53(1):77-90. PubMed ID: 22335196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B; Safa AR
    Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ras, protein kinase C zeta, and I kappa B kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T-24 carcinoma cells.
    Fitzgerald KA; Bowie AG; Skeffington BS; O'Neill LA
    J Immunol; 2000 Feb; 164(4):2053-63. PubMed ID: 10657658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2.
    Misra S; Ghatak S; Toole BP
    J Biol Chem; 2005 May; 280(21):20310-5. PubMed ID: 15784621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CBP and p300: Emerging Anticancer Agents.
    Masci D; Puxeddu M; Silvestri R; La Regina G
    Molecules; 2024 Sep; 29(19):. PubMed ID: 39407454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.